Fortrea Holdings (FTRE) Gross Margin (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Gross Margin came in at 20.52% in Q2 2026, up 173.0% on a YoY basis from 7.52% in Q2 2025, and up 5.7% quarter-over-quarter from 19.42% in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Gross Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Gross Margin for 5 consecutive years, with 20.52% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 173.0% year-over-year to 20.52%; the trailing twelve-month figure through Jun 2026 stood at 19.3% (down 42.0% YoY), and the FY2025 full-year result was 18.5%, down 131.0% from the prior year.
- Gross Margin advanced to 20.52% in Q2 2026 per FTRE's latest filing, from 19.42% in the prior quarter.
- Across five years, Gross Margin topped out at 47.27% in Q4 2022 and bottomed at 16.3% in Q1 2024.
- Historically, Gross Margin has averaged 21.65% across 5 years, with a median of 20.52% in 2026.
- The sharpest annual moves came in 2023 and 2026: Gross Margin plunged 2870 bps in 2023, then soared 173 bps in 2026.
- Over 5 years, Gross Margin stood at 47.27% in 2022, then slumped by 61 bps to 18.57% in 2023, then gained by 9 bps to 20.22% in 2024, then slipped by 2 bps to 19.85% in 2025, then gained by 3 bps to 20.52% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 20.52%, 19.42%, and 19.85% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.22 Bn | 40.14 Bn | 1.44 Bn | 32.85% |
| 2 | Medpace Holdings | 16.45 Bn | 15.95 Bn | 201.64 Mn | 28.51% |
| 3 | Charles River Laboratories International | 13.14 Bn | 12.95 Bn | 452.07 Mn | 45.02% |
| 4 | Icon | 12.38 Bn | 11.45 Bn | 479.29 Mn | 23.23% |
| 5 | Fortrea Holdings | 1.57 Bn | 1.40 Bn | 139.20 Mn | 20.52% |
| 6 | Evotec SE | 621.88 Mn | 196.00 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 418.69 Mn | 334.15 Mn | 18.44 Mn | 91.47% |
| 8 | Champions Oncology | 71.79 Mn | 71.79 Mn | 7.03 Mn | 50.78% |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 60.63% |
| 10 | VivoSim Labs | 1.44 Mn | 1.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.52% |
| Mar 31, 2026 | 19.42% |
| Dec 31, 2025 | 19.85% |
| Sep 30, 2025 | 17.50% |
| Jun 30, 2025 | 18.79% |
| Mar 31, 2025 | 17.89% |
| Dec 31, 2024 | 20.22% |
| Sep 30, 2024 | 21.97% |
| Jun 30, 2024 | 20.70% |
| Mar 31, 2024 | 16.30% |
| Dec 31, 2023 | 18.57% |
| Sep 30, 2023 | 21.01% |
| Jun 30, 2023 | 21.57% |
| Mar 31, 2023 | 21.96% |
| Dec 31, 2022 | 47.27% |
| Sep 30, 2022 | 21.97% |
| Jun 30, 2022 | 22.54% |